BackSol-Gel Technologies Overview

Sol-Gel Technologies Receivables

Latest receivables for SLGL: $710K.

Get informed when a big investor buys or sells

+ Follow
Receivables
$713000.00
↓ 92.90% YoYΔ $-9.33M vs prior year quarter

Peer trimmed avg / median

Loading

Sol-Gel Technologies Receivables History

Loading

Sol-Gel Technologies vs. peers: Receivables Comparison

Loading

Sol-Gel Technologies Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Sol-Gel Technologies (SLGL) FAQ

Sol-Gel Technologies posts a receivables of $710K as of June 2026. That compares with $10M in the prior-year period — down 92.9% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Sol-Gel Technologies's receivables was $10M. The latest reading is $710K — a 92.9% year-over-year decrease (period ending June 2026). Use the history and growth charts on this page for a longer lookback.

Receivables is one piece of Sol-Gel Technologies's financial statement story. At $710K, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for SLGL's receivables usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Sol-Gel Technologies's other metric pages and overview cover the third.

Judging Sol-Gel Technologies against Healthcare peers is usually better than using a market-wide rule of thumb. Business models inside Healthcare are more comparable, which makes gaps in receivables easier to interpret. Start with $710K here, then scan peer and history charts to see if the gap is persistent.